NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 118 filers reported holding NUVALENT INC in Q3 2023. The put-call ratio across all filers is 0.61 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $112,710,119 | -7.3% | 2,451,819 | -15.0% | 13.56% | -20.9% |
| Q2 2023 | $121,639,028 | +61.6% | 2,884,492 | 0.0% | 17.15% | +32.5% |
| Q1 2023 | $75,256,396 | -9.4% | 2,884,492 | +3.4% | 12.94% | -1.8% |
| Q4 2022 | $83,055,854 | +105.4% | 2,788,981 | +34.1% | 13.18% | +85.4% |
| Q3 2022 | $40,433,000 | +73.8% | 2,079,863 | +21.2% | 7.11% | +33.5% |
| Q2 2022 | $23,262,000 | +25.1% | 1,715,518 | +28.2% | 5.32% | +21.1% |
| Q1 2022 | $18,590,000 | +6.8% | 1,338,393 | +46.3% | 4.40% | -23.4% |
| Q4 2021 | $17,414,000 | -15.6% | 914,614 | 0.0% | 5.74% | -23.5% |
| Q3 2021 | $20,625,000 | – | 914,614 | – | 7.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,991,024 | $918,987,373 | 20.25% |
| Bain Capital Life Sciences Investors, LLC | 3,577,267 | $164,446,964 | 18.39% |
| Fairmount Funds Management LLC | 2,451,819 | $112,710,119 | 13.56% |
| Paradigm Biocapital Advisors LP | 1,638,147 | $75,305,618 | 5.11% |
| COMMODORE CAPITAL LP | 828,778 | $38,098,925 | 4.45% |
| Perceptive Advisors | 2,463,451 | $113,244,842 | 3.78% |
| Boxer Capital, LLC | 1,210,192 | $55,632,526 | 2.96% |
| Tri Locum Partners LP | 113,528 | $5,218,882 | 1.67% |
| Ikarian Capital, LLC | 278,034 | $12,781,224 | 1.54% |
| Ikarian Capital, LLC | 2,395 | $11,009,815 | 1.32% |